Similarly, the raised level of female hormones at puberty might somehow inhibit the detrimental effects of PHO-causing SLCO2A1 mutations and protected female carriers from PHO symptoms. The gene discussed is SLCO2A1; the disease is primary hypertrophic osteoarthropathy.